Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Treatment of multidrug resistant Acinetobacter.

Murray CK, Hospenthal DR.

Curr Opin Infect Dis. 2005 Dec;18(6):502-6. Review.

PMID:
16258323
2.

Factors changing the manifestation of pulmonary tuberculosis.

Wang JY, Lee LN, Hsueh PR.

Int J Tuberc Lung Dis. 2005 Jul;9(7):777-83.

PMID:
16013774
3.

Mycobacterium tuberculosis inducing disseminated intravascular coagulation.

Wang JY, Hsueh PR, Lee LN, Liaw YS, Shau WY, Yang PC, Luh KT.

Thromb Haemost. 2005 Apr;93(4):729-34.

PMID:
15841321
4.

Impact of empiric antibiotics and chest radiograph on delays in the diagnosis of tuberculosis.

Golub JE, Bur S, Cronin WA, Gange S, Sterling TR, Oden B, Baruch N, Comstock GW, Chaisson RE.

Int J Tuberc Lung Dis. 2005 Apr;9(4):392-7.

PMID:
15832463
5.

Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes.

Hsu DI, Okamoto MP, Murthy R, Wong-Beringer A.

J Antimicrob Chemother. 2005 Apr;55(4):535-41. Epub 2005 Feb 22.

PMID:
15728150
6.

Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and Canada.

Bozeman L, Burman W, Metchock B, Welch L, Weiner M; Tuberculosis Trials Consortium..

Clin Infect Dis. 2005 Feb 1;40(3):386-91. Epub 2005 Jan 7.

PMID:
15668861
7.

Performance assessment of a nested-PCR assay (the RAPID BAP-MTB) and the BD ProbeTec ET system for detection of Mycobacterium tuberculosis in clinical specimens.

Wang JY, Lee LN, Chou CS, Huang CY, Wang SK, Lai HC, Hsueh PR, Luh KT.

J Clin Microbiol. 2004 Oct;42(10):4599-603.

8.

Fluoroquinolone resistance in patients with newly diagnosed tuberculosis.

Ginsburg AS, Hooper N, Parrish N, Dooley KE, Dorman SE, Booth J, Diener-West M, Merz WG, Bishai WR, Sterling TR.

Clin Infect Dis. 2003 Dec 1;37(11):1448-52. Epub 2003 Nov 4.

PMID:
14614666
9.

The rapid development of fluoroquinolone resistance in M. tuberculosis.

Ginsburg AS, Woolwine SC, Hooper N, Benjamin WH Jr, Bishai WR, Dorman SE, Sterling TR.

N Engl J Med. 2003 Nov 13;349(20):1977-8. No abstract available.

10.

Two decades of disseminated tuberculosis at a university medical center: the expanding role of mycobacterial blood culture.

Crump JA, Reller LB.

Clin Infect Dis. 2003 Oct 15;37(8):1037-43. Epub 2003 Sep 24.

PMID:
14523767
11.

TB should be diagnosed before using a fluoroquinolone.

Agarwal A.

BMJ. 2003 Jul 19;327(7407):164-5. No abstract available.

12.

Does the use of fluoroquinolones for the empiric treatment of pneumonia delay initiation of treatment of tuberculosis?

Abiad H.

Clin Infect Dis. 2002 Dec 15;35(12):1572; author reply 1572-3. No abstract available.

PMID:
12471582
13.

Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis.

Dooley KE, Golub J, Goes FS, Merz WG, Sterling TR.

Clin Infect Dis. 2002 Jun 15;34(12):1607-12. Epub 2002 May 23.

PMID:
12032896
14.

Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors.

Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, Chaisson RE.

Clin Infect Dis. 2002 Mar 15;34(6):752-9. Epub 2002 Feb 7.

PMID:
11850859
15.

National patterns in the treatment of urinary tract infections in women by ambulatory care physicians.

Huang ES, Stafford RS.

Arch Intern Med. 2002 Jan 14;162(1):41-7.

PMID:
11784218
16.

Can administration of a fluoroquinolone delay diagnosis of pulmonary tuberculosis?

KiaNoury D, Timpone J, Yeager H Jr.

Int J Tuberc Lung Dis. 2000 Nov;4(11):1092. No abstract available.

PMID:
11092727
17.

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ.

Clin Infect Dis. 2000 Aug;31(2):347-82. Epub 2000 Sep 7. No abstract available.

PMID:
10987697
18.

Infections in patients with diabetes mellitus.

Joshi N, Caputo GM, Weitekamp MR, Karchmer AW.

N Engl J Med. 1999 Dec 16;341(25):1906-12. Review. No abstract available.

PMID:
10601511
19.

How tumors escape immune destruction and what we can do about it.

Gilboa E.

Cancer Immunol Immunother. 1999 Oct;48(7):382-5. Review.

PMID:
10501851
20.

The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis.

Pablos-Méndez A, Sterling TR, Frieden TR.

JAMA. 1996 Oct 16;276(15):1223-8.

PMID:
8849749

Supplemental Content

Support Center